Skip to main content
Premium Trial:

Request an Annual Quote

Molecular Staging, Scripps Get NIDDK Grant for Genomic DNA Samples

NEW YORK, Feb. 4 - Molecular Staging of New Haven, Conn., and the Scripps Research Institute have won an award totaling up to $2.5 million from the National Institute of Diabetes and Digestive and Kidney disease (NIDDK) to produce large samples of genomic DNA for genetic disease studies, the company said today.

 

The purpose of the grant, which will be spread over two and a half years, is to provide academic researchers with DNA samples from well-characterized patient population groups, without having to pay private corporations that own most of these samples, according to Molecular Staging.

 

About 8,000 samples of genomic DNA will be taken from patient samples from Scripps collection, and will be made available to the scientific community. Ernest Beutler, chairman of the department of molecular and experimental medicine at Scripps, will supervise this process, making sure to only provide samples from patients who have given informed consent.

 

Molecular Staging will use its.REPLI-g whole genome amplification method in order to copy the samples, the company said.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.